CGEM Competitors & Alternatives
Compare Cullinan Oncology LLC with similar stocks in the same industry
Biotechnology
CGEM
Main Stock$16.50
Tradestie Score
55
Market Cap
$354.45M
Analyst Upside
+91.7%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
INVA
Innoviva, Inc. Common Stock
|
$20.97
|
$1.15B | 3.5 | 49 | Compare |
|
TRVI
Trevi Therapeutics, Inc. Common Stock
|
$18.25
|
$1.14B | - | 55 | Compare |
|
ORIC
Oric Pharmaceuticals, Inc. Common Stock
|
$11.07
|
$1.14B | - | 54 | Compare |
|
MAZE
Maze Therapeutics, Inc. Common Stock
|
$26.92
|
$1.13B | - | 54 | Compare |
|
WVE
Wave Life Sciences Ltd. Ordinary Shares
|
$5.51
|
$1.12B | - | 49 | Compare |
|
NKTR
Nektar Therapeutics
|
$70.67
|
$1.12B | - | 63 | Compare |
|
PRAX
Praxis Precision Medicines, Inc. Common Stock
|
$307.83
|
$1.12B | - | 49 | Compare |
|
IMTX
Immatics N.V. Ordinary Shares
|
$8.66
|
$1.09B | - | 48 | Compare |
|
PHAR
Pharming Group N.V. ADS, each representing 10 ordinary shares
|
$10.08
|
$1.05B | 76.8 | 41 | Compare |
|
MDXG
MiMedx Group, Inc
|
$4.13
|
$1.01B | 21.4 | 53 | Compare |
More CGEM Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2836)
231 stocks in this industry